
BioCancell has begun enrollment of phase IIb BC-819 pancreatic cancer clinical trial, while Halozyme has started randomized, controlled clinical trial with PEGPH20 in patients with advanced pancreatic cancer. Tikcro Technologies Ltd. announced on October 6 that BioCancell, a clinical stage biotechnology company focused on developing targeted cancer therapies for solid cancer tumors, has co…

g drug for patients with advanced pancreatic cancer. After the first phase of the study, the recommended Phase II dose was 125 mg/m2 of Abraxane followed by 1000 mg/m2 of gemcitabine on days 1, 8 and 15 of every 28-day cycle. In Phase II, almost half of the patients responded (overall response rate was 48% (21/44)) and two-thirds experienced disease control (disease control rate was 68% (30…

y engineered patients’ T cells to attack cancer cells in advanced cases of a common type of leukemia. Two of three patients studied have been cancer-free for more than one year. In the third case over 70% of cancer cells were removed. Researchers from Lund University have identified a method that may attack and destroy prostate cancer stem cells and might lead to a complete cure. Autumn crocus ext…
Sep 27 2011 | Posted in
Health |
Read More » 
…swedish prostate breakthrough xxnlxx video punjib prostate cancer laser treatment commercial advance grey hair treatment science 2013 advanced prostate cancer breakthrough breakthrough in aides march 3 2013 did warren beatty have cancer emphysema break through 2013 enlarged prostate technology breakthroughs Fried Potatoes Cance latest report r german swedish clothing gery hair treatment in 2013 m…

…a common type of leukemia. The first two of three patients studied, who received the innovative treatment, have been cancer-free for more than one year. In the case of the third patient, over 70% of cancer cells were removed, according to the researchers. "Microscopic image showing two T cells binding to beads, depicted in yellow, that cause the cells to divide. After the bea…

ms divided by the square of his/her height in meters). A normal BMI ranges from 18.5 to 25. For children there is another calculation that implies age and sex. A person under 20 with a BMI between the 85th and 95th percentile is overweight. Another study showed that obesity multiplied the risk of metastases by 5 and prostate cancer grew 3 times faster in obese patients. The study was presented in…

…en with PSA levels in the safe range have been found to harbor cancer cells in their prostates. Autopsy studies have found prostate cancer in one-third of men between 40 and 60, and in 75% of men over 85; in most of those cases, the cancers are harmless. “Many men with localized prostate cancer will never have problems,” said Dr. Roger Chou of Oregon Health & Science University, pa…

…s based on the results of the barcode test. One of these groups fared far worse, surviving for significantly less time than the other patients. The researchers then confirmed their findings in another 70 US patients with advanced cancer, which revealed that nine genes could accurately spot who had the least chance of survival. Patients with this “bad” gene signature survived for an ave…
Oct 9 2012 | Posted in
Health |
Read More » 
r cells on the prostate. This was a “proof of concept” study involving 41 patients. They used a probe, placed close to the prostate, which emits sound waves that heat the targeted cells to 80C, while causing minimal damage to surrounding nerves and muscles. Hashim Ahmed, a urological surgeon at the trust who led the study, says the results, 12 months after treatment, are very encouragi…

…out Dr Megan Hitchins. In one well studied cause of hereditary cancer, alterations in the cancer-prevention gene MLH1 are transferred from mother or father to children. This situation generates up to 80 percent risk of developing bowel cancer, uterine cancer and other malignancies. On the other hand, a number of family members with hereditary cancer do not have spelling mistakes in MLH1, but alte…

nt side-effects." say experts, making a special reference to terminal cancer. In UK around 310,000 people are diagnosed with cancer every year and by 2030 this is expected to have risen to 400,000. The National Health Service spends over £5billion annually on cancer treatments, up from £3billion in 2002. “All health systems face budget limitations, while at the same time the canc…

offer a prostate cancer-specific benefit,” said June Chan, associate professor of epidemiology and biostatistics, and urology at the University of California, San Francisco. Prostate genes from 70 men with low-risk prostate cancer were compared to normal prostate genes from 70 men by Professor Chan’s team. Researchers discovered a great difference between the expression of the genes i…

…xist. CITATION: Martinez-Delgado B, Yanowsky K, Inglada-Perez L, Domingo S, Urioste M, et al. (2011) Genetic Anticipation Is Associated with Telomere Shortening in Hereditary Breast Cancer. PLoS Genet 7(7): e1002182. doi:10.1371/journal.pgen.1002182 Contact: Dr. Beatriz Martinez-Delgado and Dr. Javier Benitez Spanish National Cancer Research Centre (CNIO) Human Genetics Melchor Fernandez Almagro…

d it did not know if tea was a risk factor or if drinkers lived to ages where cancer was more common. Prostate cancer is the most common cancer amongst men in Scotland and diagnosed cases increased by 7.4% between 2000 and 2010. The Midspan Collaborative study began in Scotland in 1970 and gathered data from 6,016 male volunteers, all aged between 21 and 75. Volunteers were asked to complete a que…

are the risk factors. The BRAF gene is essential in normal cell growth and survival. BRAF mutations may lead to uncontrolled cell growth. These mutations can be found in around 50% of melanoma and in 8% of solid tumors. After receiving the FDA approval in August 2011, Zelboraf was approved by the European Commission for the treatment of inoperable or metastatic melanoma. Zelboraf ha…

A couple of hamburgers a week could increase the chances of getting prostate cancer by 40%, according to new a research. Scientists say cooking meat at a high temperatures creates cancer causing chemicals that damage DNA. A study of almost 2,000 men found prostate cancer cases rose dramatically in those who often ate meat cooked in a pan, with red meat being particularly dangerous. Professor Mari…
Aug 18 2012 | Posted in
Health |
Read More » 
comes in ATC. There were three key findings from the retrospective analysis. 13 patients or 9.7% of all 134 ATC patients treated at the Mayo Clinic survived one year or more. 19 patients or 23% of all 84 ATC patients treated with Zybrestat either alone or in combination with chemotherapy survived more than one year. The longest survival is 13+ years in a patient with a complete response. The 9% ra…

…and june divorce danielle pagano implants cancer research in texas using IMmucin beverly hills sugar daddy bell nantita attempted murder cases cause outrage athletes bladder cancer with arthur morgan 3 murder trial are vaccines the breakthrough for cancer ethiopian half woman half snake half human half creature to abay river half human half snake at compostela valley kate upton wins best breast i…

uncement Melanoma is the leading cause of death from skin disease. The National Cancer Institute estimated that 68,130 new cases of melanoma were diagnosed in the United States during 2010; about 8,700 people died from the disease. Zelboraf is marketed by South San Francisco based-Genentech, a member of the Roche Group. The cobas 4800 BRAF V600 Mutation Test is manufactured by Roche Molecular…

alpha radiation drug) trial has been so successful researchers have decided to stop it early. Specialists at London’s Royal Marsden Hospital, UK, were testing a powerful alpha radiation drug on 461 patients while another group of the same number was being treated with placebo. The group taking the new drug experienced less pain, side effects and lived longer. British doctors were so astound…
Sep 25 2011 | Posted in
Health |
Read More » 
igators, collaborators and dedicated employees, who have all contributed to this important advancement in cancer treatment,” said K. Peter Hirth, Ph.D., chief executive officer of Plexxikon. The cobas 4800 BRAF V600 Mutation Test identifies tumors that carry the BRAF V600E mutation. In this way the doctors will know what person with inoperable or metastatic melanoma can be treated with Zelboraf. T…
s and potato chips are not the only foods that contain acrylamide, but they are the most common and have high levels. Baked goods, especially doughnuts, also have relatively high levels of acrylamide. 8. Artificial Sweeteners Artificial sweeteners – aspartame, cyclamate, neotame, saccharin, or sucralose – can be found in a wide variety of processed foods, many of which are promoted as…
Jan 14 2012 | Posted in
Health,
How To... |
Read More » 
commercialization rights and the Takeda Group has rights to commercialize Adcetris in the rest of the world. Seattle Genetics and the Takeda Group are funding joint development costs for Adcetris on a 50:50 basis, except in Japan, where the Takeda Group will be solely responsible for development costs. Related search articles:Powered by Article Dashboard india v australia test series myfemaleagen…

atitis C is extremely rare transmitted through sexual intercourse. Worldwide around 170 million people are infected with hepatitis C, especially with genotype 1. The chronic infection occurs in almost 80% of them. Twenty percent of persons with chronic hepatitis C are at risk of developing cirrhosis and, of those, up to 25 percent may progress to liver cancer. There is no vaccine to prevent hepati…

PCV chemotherapy. The good news comes when it is about the patients with the rare form of brain tumor, 1p19q co-deleted tumors. The 126 patients with co-deletion lived more (a median survival rate of 8.7 years) than the 135 patients with tumors without the co-deletion (2.7 years). The 59 patients with co-deletion tumors who received PCV chemotherapy plus radiotherapy lived much longer, double tim…